Newswise — Following is a tipsheet of story ideas from Cedars-Sinai Medical Center. To arrange interviews, please contact the individual listed for each item.
1. Latinos more vulnerable to fatty pancreas, Type 2 diabetes, Cedars-Sinai study shows - Latinos are more likely to store fat in the pancreas and are less able to compensate by excreting additional insulin, a Cedars-Sinai study shows.CONTACT: Nicole White, 310-423-5215; Email Nicole.White@cshs.org.
2. Cedars-Sinai Heart Institute awarded $1.3 million to study cardiac stem cells - A team of Cedars-Sinai Heart Institute stem cell researchers today was awarded a $1.3 million grant from the California Institute of Regenerative Medicine to continue study of an experimental stem cell therapy that treats heart attack patients with heart-derived cells. Earlier this year, data from the first clinical trial of the stem cell treatment showed the therapy helped damaged hearts regrow healthy muscle.CONTACT: Sally Stewart, 310-248-6566; Email Sally.Stewart@cshs.org.
In war with ‘superbugs,’ Cedars-Sinai researchers see new weapon: immune-boosting vitamin - Cedars-Sinai researchers have found that a common vitamin may have the potential to provide a powerful weapon to fight certain “superbugs,” antibiotic-resistant staph infections that health experts see as a threat to public health. The research found that high doses of the nicotinamide form of vitamin B3 stimulated a specific gene, enhancing white blood cells’ ability to combat staph infections, including methicillin-resistant Staphylococcus aureus or MRSA. CONTACT: Nicole White, 310-423-5215; Email Nicole.White@cshs.org.
Grant supports study of depression in patients battling multiple sclerosis - Living every day with a life-changing illness is discouraging enough, but Maryam Hosseinzadeh is one of 400,000 people in the United States battling multiple sclerosis, a disorder that by changing the brain’s makeup appears capable of generating the secondary ill of depression. PATIENT/PHYSICIAN INTERVIEWS AVAILABLE.CONTACT: Sandy Van, 808-526-1708; Email email@example.com.
Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival - An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor. Median survival in a Phase I clinical trial was 38.4 months, significantly longer than the typical 14.6-month survival of patients with newly diagnosed glioblastoma receiving standard therapy alone (radiation and chemotherapy). Median progression-free survival – the time from treatment to tumor recurrence – was 16.9 months, compared to 6.9 months with standard care. B-ROLL AVAILABLE.CONTACT: Sandy Van, 808-526-1708; Email firstname.lastname@example.org.
Researchers link Kawasaki Disease in childhood with increased risk of adult heart disease - Cedars-Sinai researchers have linked Kawasaki Disease, a serious childhood illness that causes inflammation of blood vessels throughout the body, with early-onset and accelerated atherosclerosis, a leading cause of heart disease in adults. CONTACT: Sally Stewart, 310-248-6566; Email Sally.Stewart@cshs.org.
Cedars-Sinai Medical Center studies galaxy-exploring camera in the operating room - Neurosurgeons and researchers at Cedars-Sinai Medical Center and the Maxine Dunitz Neurosurgical Institute are adapting an ultraviolet camera to possibly bring planet-exploring technology into the operating room. If the system works when focused on brain tissue, it could give surgeons a real-time view of changes invisible to the naked eye and unapparent even with magnification of current medical imaging technologies. The pilot study seeks to determine if the camera provides visual detail that might help surgeons distinguish areas of healthy brain from deadly tumors called gliomas, which have irregular borders as they spread into normal tissue. PHOTOS AVAILABLE.CONTACT: Sandy Van, 808-526-1708; Email email@example.com.
Cedars-Sinai awarded $17.8 million grant to develop ALS treatment - Cedars-Sinai Regenerative Medicine Institute today was awarded a $17.8 million grant from the California Institute for Regenerative Medicine to develop stem cell treatments for patients with ALS, also known as Lou Gehrig’s Disease, a progressive, fatal and currently incurable neurodegenerative disease. The grant will fund a project with combined stem cell and gene therapy to treat amyotrophic lateral sclerosis with stem cells found in early brain development and a protein called GDNF that promotes the survival of neurons. CONTACT: Nicole White, 310-423-5215; Email Nicole.White@cshs.org.
# # #
VIDEOLINK ENABLEDThanks to a new, state-of-the-art in-house studio, Cedars-Sinai Medical Center can now instantly broadcast quality HD video directly to newsrooms around the world.